Clinical trial
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
NCT01722604 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- September 30, 2012
- Enrollment
- 258 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, open angle or ocular hypertension